Last reviewed · How we verify
diluted sodium bicarbonate 2.1%
At a glance
| Generic name | diluted sodium bicarbonate 2.1% |
|---|---|
| Also known as | sodium bicarbonate 2.1% |
| Sponsor | Sheba Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Children (PHASE1, PHASE2)
- Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- diluted sodium bicarbonate 2.1% CI brief — competitive landscape report
- diluted sodium bicarbonate 2.1% updates RSS · CI watch RSS
- Sheba Medical Center portfolio CI